Forget Snowflake! This Healthcare IPO Is a Better Buy
Investors who missed out on the Snowflake (NYSE: SNOW) initial public offering (IPO) might not want to pay double the price for its shares now, especially while it trades at over 100 times its annualized sales. Another company that's debuting on the market next week should be on investor's radars instead.
Amid the most polarized political climate in years, GoodRx will help drive healthcare in a direction embraced by both sides of the aisle.
Source Fool.com